We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$752M
AUM Growth
+$253M
Cap. Flow
+$268M
Cap. Flow %
35.64%
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17

Top Buys

Rank Stock Value
1
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
+$17.4M
2
AAPL icon
Apple
AAPL
+$7.52M
3
AVGO icon
Broadcom
AVGO
+$6.81M
4
BHC icon
Bausch Health
BHC
+$5.93M
5
NBIS
Nebius Group N.V.
NBIS
+$4.82M

Top Sells

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$2.86M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$1.98M
3
EGLE
Eagle Bulk Shipping Inc.
EGLE
+$1.84M
4
ALTR
Altera Corp
ALTR
+$1.74M
5
PCYC
PHARMACYCLICS INC
PCYC
+$1.64M

Sector Composition

Rank Sector Weight
1 Technology 15.2%
2 Healthcare 13.08%
3 Industrials 11.83%
4 Financials 9.36%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVR icon
101
NVR
NVR
$16.9B
$1.84M 0.24%
1,373
+326
+31% +$440K
V icon
102
Visa
V
$692B
$1.84M 0.24%
27,373
-13,379
-33% -$907K
FARO
103
DELISTED
Faro Technologies
FARO
$1.84M 0.24%
+39,338
New +$1.85M
TFCF
104
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$1.82M 0.24%
+56,616
New +$1.88M
CCK icon
105
Crown Holdings
CCK
$13.2B
$1.82M 0.24%
+34,318
New +$1.89M
CLVS
106
DELISTED
Clovis Oncology, Inc.
CLVS
$1.8M 0.24%
+20,526
New +$1.76M
RAI
107
DELISTED
Reynolds American Inc
RAI
$1.8M 0.24%
48,270
+13,256
+38% +$496K
UTHR icon
108
United Therapeutics
UTHR
$22.6B
$1.8M 0.24%
10,348
+1,410
+16% +$254K
CHTR icon
109
Charter Communications
CHTR
$18.8B
$1.8M 0.24%
10,508
+2,846
+37% +$512K
NVS icon
110
Novartis
NVS
$293B
$1.79M 0.24%
20,300
+4,869
+32% +$447K
IMMR icon
111
Immersion
IMMR
$246M
$1.76M 0.23%
+138,612
New +$1.57M
NATI
112
DELISTED
National Instruments Corp
NATI
$1.74M 0.23%
59,080
+37,720
+177% +$1.16M
BABA icon
113
Alibaba
BABA
$304B
$1.73M 0.23%
21,042
-11,591
-36% -$996K
NOC icon
114
Northrop Grumman
NOC
$80.7B
$1.73M 0.23%
10,898
+7,530
+224% +$1.21M
K
115
DELISTED
Kellanova
K
$1.73M 0.23%
29,292
+1,887
+7% +$113K
RAX
116
DELISTED
Rackspace Hosting Inc
RAX
$1.73M 0.23%
46,396
+18,205
+65% +$837K
ACHN
117
DELISTED
Achillion Pharmaceuticals
ACHN
$1.72M 0.23%
+193,930
New +$1.83M
LUV icon
118
Southwest Airlines
LUV
$23B
$1.71M 0.23%
51,805
+20,170
+64% +$789K
SPY icon
119
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$1.71M 0.23%
+8,319
New +$1.75M
IMKTA icon
120
Ingles Markets
IMKTA
$1.65B
$1.71M 0.23%
35,804
+1,677
+5% +$80.9K
VIPS icon
121
Vipshop
VIPS
$7.4B
$1.71M 0.23%
+76,865
New +$2.04M
ARAY icon
122
Accuray
ARAY
$33.8M
$1.71M 0.23%
+253,439
New +$1.89M
AZTA icon
123
Azenta
AZTA
$1.42B
$1.69M 0.22%
147,300
+103,282
+235% +$1.18M
CPN
124
DELISTED
Calpine Corporation
CPN
$1.67M 0.22%
92,951
-37,074
-29% -$773K
GMCR
125
DELISTED
KEURIG GREEN MTN INC
GMCR
$1.67M 0.22%
21,807
+10,632
+95% +$1.04M
3 4
5
6 7

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2015 Portfolio in Review

As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.

  • Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
  • Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
  • Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
  • Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
  • Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
  • Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
  • Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.

Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.